BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
20 among them to receive $20,000 grants
Subscribe To Our Newsletter & Stay Updated
